Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v6-FR
Language French French
Date Updated 2017-04-06 2017-04-06
Drug Identification Number 02357585 02357585
Brand name IRINOTECAN HYDROCHLORIDE TRIHYDRATE FOR INJECTION IRINOTECAN HYDROCHLORIDE TRIHYDRATE FOR INJECTION
Common or Proper name IRINOTECAN IRINOTECAN
Company Name ACCORD HEALTHCARE INC ACCORD HEALTHCARE INC
Ingredients IRINOTECAN HYDROCHLORIDE IRINOTECAN HYDROCHLORIDE
Strength(s) 20MG 20MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 5 ML VIAL OF 100 MG | FLACON DE 5 ML DE 100 MG 5 ML VIAL OF 100 MG | FLACON DE 5 ML DE 100 MG
ATC code L01XX L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2016-12-27 2016-12-27
Actual start date 2016-12-27 2016-12-27
Estimated end date 2017-03-22 2017-03-22
Actual end date 2017-03-22 2017-03-22
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments